IntelliPharmaCeutics International (TSXV:IPCI) FCF Margin % : 349.46% (As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. IntelliPharmaCeutics International's Free Cash Flow for the three months ended in Aug. 2023 was C$0.33 Mil. IntelliPharmaCeutics International's Revenue for the three months ended in Aug. 2023 was C$0.09 Mil. Therefore, IntelliPharmaCeutics International's FCF Margin % for the quarter that ended in Aug. 2023 was 349.46%.

As of today, IntelliPharmaCeutics International's current FCF Yield % is 6.20%.

The historical rank and industry rank for IntelliPharmaCeutics International's FCF Margin % or its related term are showing as below:

TSXV:IPCI' s FCF Margin % Range Over the Past 10 Years
Min: -2098.88 Med: -191.84 Max: 13.43
Current: 13.43

During the past 13 years, the highest FCF Margin % of IntelliPharmaCeutics International was 13.43%. The lowest was -2098.88%. And the median was -191.84%.

TSXV:IPCI's FCF Margin % is ranked better than
88.88% of 1034 companies
in the Biotechnology industry
Industry Median: -148.935 vs TSXV:IPCI: 13.43

IntelliPharmaCeutics International FCF Margin % Historical Data

The historical data trend for IntelliPharmaCeutics International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International FCF Margin % Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

FCF Margin %

Get a 7-Day Free Trial

-736.12

-191.84

7.69

-2,098.88

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
FCF Margin %	Get a 7-Day Free Trial															-1,512.00	-660.00	-4.33	18.80	349.46

Competitive Comparison of IntelliPharmaCeutics International's FCF Margin %

For the Biotechnology subindustry, IntelliPharmaCeutics International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's FCF Margin % falls into.

IntelliPharmaCeutics International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

IntelliPharmaCeutics International's FCF Margin for the fiscal year that ended in Nov. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Nov. 2022 )	/	Revenue (A: Nov. 2022 )
	=	-1.868	/	0.089
	=	-2,098.88 %

IntelliPharmaCeutics International's FCF Margin for the quarter that ended in Aug. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Aug. 2023 )	/	Revenue (Q: Aug. 2023 )
	=	0.325	/	0.093
	=	349.46 %

IntelliPharmaCeutics International FCF Margin % Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines